Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. Source: BioSpace You Might Also Like FDA Calls Novartis' Melanoma Combo Drug a Breakthrough October 22, 2017 What Does It Take to Get Hired by GlaxoSmithKline and AbbVie July 5, 2017 Massachusetts Upstart Takes on Mighty Purdue Pharma Over Tougher-to-Abuse Opioids November 21, 2017
